Literature DB >> 1286869

Mono- and bivalent antibody fragments produced in Escherichia coli: engineering, folding and antigen binding.

A Plückthun1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1286869     DOI： 10.1111/j.1600-065x.1992.tb01525.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  17 in total

1.  Development of human monoclonal antibodies: A review.

Authors:  T Lindl
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Combined effect of protein fusion and signal sequence greatly enhances the production of recombinant human GM-CSF in Escherichia coli.

Authors:  Palash Bhattacharya; Gaurav Pandey; Poonam Srivastava; Krishna Jyoti Mukherjee
Journal:  Mol Biotechnol       Date:  2005-06       Impact factor: 2.695

3.  Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils.

Authors:  Gernot Habicht; Christian Haupt; Ralf P Friedrich; Peter Hortschansky; Carsten Sachse; Jessica Meinhardt; Karin Wieligmann; Gerald P Gellermann; Michael Brodhun; Jürgen Götz; Karl-Jürgen Halbhuber; Christoph Röcken; Uwe Horn; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

4.  Antigen binding forces of individually addressed single-chain Fv antibody molecules.

Authors:  R Ros; F Schwesinger; D Anselmetti; M Kubon; R Schäfer; A Plückthun; L Tiefenauer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

5.  Targeted infection of human cells via major histocompatibility complex class I molecules by Moloney murine leukemia virus-derived viruses displaying single-chain antibody fragment-envelope fusion proteins.

Authors:  M Marin; D Noël; S Valsesia-Wittman; F Brockly; M Etienne-Julan; S Russell; F L Cosset; M Piechaczyk
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

6.  Cloning, expression, and crystallization of the V delta domain of a human gamma delta T-cell receptor.

Authors:  M I Lebedeva; B A Fields; H Spits; G Panchamoorthy; M B Brenner; R A Mariuzza
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

7.  Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.

Authors:  Robert J Benschop; Chi-Kin Chow; Yu Tian; James Nelson; Barbra Barmettler; Shane Atwell; David Clawson; Qing Chai; Bryan Jones; Jon Fitchett; Stacy Torgerson; Yan Ji; Holly Bina; Ningjie Hu; Mahmoud Ghanem; Joseph Manetta; Victor J Wroblewski; Jirong Lu; Barrett W Allan
Journal:  MAbs       Date:  2019-06-10       Impact factor: 5.857

Review 8.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09

9.  Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA.

Authors:  Kristin S Gunnarsen; Elin Lunde; Per E Kristiansen; Bjarne Bogen; Inger Sandlie; Geir Å Løset
Journal:  BMC Biotechnol       Date:  2010-02-03       Impact factor: 2.563

10.  Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutralization potency and breadth.

Authors:  Elena Gustchina; John M Louis; Christian Frisch; Francisco Ylera; Annette Lechner; Carole A Bewley; G Marius Clore
Journal:  Virology       Date:  2009-08-19       Impact factor: 3.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.